Kymera Therapeutics (KYMR) PT Raised to $41 at B.Riley

November 1, 2024 5:59 AM

B.Riley analyst Kalpit Patel raised the price target on Kymera Therapeutics (NASDAQ: KYMR) to $41.00 (from $36.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found